ElevenLabs Launches Eleven Music in Collaboration with Music Industry Partners
ElevenLabs, the leading AI audio research and product company, today announced the launch of Eleven Music, expanding on its mission to build the most comprehensive AI audio platform in the world. Eleven Music enables businesses, creators, artists, and everyday users to generate studio-grade music from natural language prompts. Eleven Music was built in partnership with artists, labels, and publishers, and includes guardrails to protect rightsholders.
Eleven Music users can effortlessly generate their ideal track, in any genre or style, with or without vocals, in numerous languages – and in a matter of minutes. Generated tracks can be used for nearly any application. ElevenLabs plans to integrate Eleven Music into its full suite of tools, including its Conversational AI platform.
“As an AI audio company, expanding into music was a natural progression, and we are thrilled to introduce Eleven Music today,” said Mati Staniszewski, CEO and Co-Founder of ElevenLabs. “We’ve heard massive demand from our enterprise partners and users for a music model like this and we took our time to ship one that we’re certain they’ll love. We’re proud to do so in collaboration with music industry partners who recognize the vast benefits and possibilities of AI innovation in music.”
ElevenLabs has worked with a range of partners to develop the first Eleven Music model. In addition, ElevenLabs has reached agreements with Merlin – the digital music licensing partner for the world’s leading independent labels and distributors – and Kobalt – the largest independent music publisher in the world. These groundbreaking deals will allow the premier artists and songwriters that Merlin and Kobalt represent to participate in the development of Eleven Music Pro, a subsequent model that the company plans to release in the coming months. The Merlin and Kobalt partnerships will help ElevenLabs continue to deliver the best AI audio tools to its millions of users.
“We are excited to partner with ElevenLabs,” said Jeremy Sirota, CEO of Merlin. “As we navigate the transformative yet challenging opportunities that AI presents, it is core to Merlin’s mission that we work with partners who respect the extraordinary cultural contribution of our members, their artists and their music. We will be very deliberate about who we work with and have been in conversations with many companies in this space. Our partnership with ElevenLabs demonstrates that music rightsholders can negotiate thoughtful, forward-looking agreements with AI companies. Together, we have created responsible guardrails that showcase how AI companies and music rightsholders can collaborate. We look forward to sharing further announcements as we work together towards the launch of Eleven Music Pro.”
Laurent Hubert, CEO of Kobalt said: “Our songwriters and clients entrust us to ensure that the AI revolution includes both strong protections for their intellectual property rights for AI training, as well as forward-looking and thoughtful opportunities to participate in AI revenue streams, subject to clear and fair guardrails. ElevenLabs has been a collaborative partner, committed to sourcing data directly from rightsholders and protecting them. We are excited about this partnership and seeing ElevenLabs become a pioneer in licensing premium music for their Music Pro offering. Kobalt looks forward to working with our songwriters and partners who wish to be part of this opportunity with ElevenLabs.”
Eleven Music is available today on the ElevenLabs website. Outputs are cleared for broad commercial use. For more information on supported usage, please visit elevenlabs.io/music-terms.
About ElevenLabs
Founded in 2022, ElevenLabs is the global leader in AI audio research and technology, building cutting-edge AI audio tools for enterprises, developers, creators, and artists. The platform empowers millions of individuals and thousands of businesses, including employees from over 72% of the Fortune 500, to quickly and affordably create high-quality voice overs at scale, launch interactive AI voice agents in over 30 languages, and now generate studio-quality music.
About Merlin
Merlin is the digital music licensing partner for the world’s leading independent labels and distributors. We’ve negotiated premium deals with Apple, Canva, Meta, Spotify, YouTube, and 40 other innovative platforms around the world. Our global membership is from 70+ countries around the world, representing 15% of the recorded music market. Merlin operates for the benefit of its members, without investors looking for an exit, and is funded entirely by our low 1.5% admin fee. Merlin helps the world’s leading independents to own their digital business through world-class deals and white-glove support.
Find out more at www.merlinnetwork.org.
About Kobalt
Kobalt Music is the leading independent music publishing destination for songwriters and publishers, powered by technology. Across 10 global offices, Kobalt serves over 1 Million songs, representing some of the biggest songwriters in the world. On average, Kobalt represents over 35% of the top 100 songs and albums in the US and the UK. With a relentless focus on advancing the interests of creators, Kobalt leverages cutting-edge technology to streamline the complex processes of music publishing administration. The company’s dedication to transparency, coupled with its forward-thinking approach, has positioned it as a trusted partner for songwriters and rights holders navigating the ever-evolving music industry.
Kobalt’s unwavering commitment to empowering creators and reshaping the future of music rights management solidifies its standing as a global leader in the music industry. The company continues to transform the industry, most recently via AMRA, its global digital music collection society designed to maximize value for songwriters and publishers in today's digital age, while providing the highest level of transparency and efficiency. For more information about Kobalt, please visit www.kobaltmusic.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250805333301/en/
Contacts
ElevenLabs Press Contact:
Sarah Bauer, press@elevenlabs.io
Merlin Press Contact:
Crystal Henderson, crystal@thepresshouse.com
Kobalt Press Contact:
John Vlautin, jv@spinlab.net
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom